Ironwood Pharma (IRWD) Posts Mixed Q1 Results

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.34), $0.10 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $12.25 million versus the consensus estimate of $9.48 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• American Healthcare REIT, Inc (AHR) PT Raised to $68 at KeyBanc
• Cosmos Health posts 29% revenue rise in Q2 but net loss widens